Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data
时间:2024.04.25 发布来源:本站原创
Ning Lou, Xinge Cui, Xinyuan Lin, et al. Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data. Transl Lung Cancer Res 2024;13(4):706-720 | https://dx.doi.org/10.21037/tlcr-23-737
上一条:Novel Structure-Dr...
下一条:Primed 3D injectab...